Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
February-2021 Volume 47 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2021 Volume 47 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

MicroRNA‑34a‑5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study

  • Authors:
    • Ilaria Grossi
    • Annalisa Radeghieri
    • Lucia Paolini
    • Vanessa Porrini
    • Andrea Pilotto
    • Alessandro Padovani
    • Alessandra Marengoni
    • Alessandro Barbon
    • Arianna Bellucci
    • Marina Pizzi
    • Alessandro Salvi
    • Giuseppina De Petro
  • View Affiliations / Copyright

    Affiliations: Department of Molecular and Translational Medicine, University of Brescia, I‑25123 Brescia, Italy, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, I‑25123 Brescia, Italy, General Medicine and Geriatrics Unit, Department of Clinical and Experimental Sciences, University of Brescia, I‑25123 Brescia, Italy
    Copyright: © Grossi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 533-546
    |
    Published online on: December 2, 2020
       https://doi.org/10.3892/ijmm.2020.4806
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Parkinson's disease (PD) is an important disabling age‑related disorder and is the second most common neurodegenerative disease. Currently, no established molecular biomarkers exist for the early diagnosis of PD. Circulating microRNAs (miRNAs), either vesicle‑free or encapsulated in extracellular vesicles (EVs), have emerged as potential blood‑based biomarkers also for neurodegenerative diseases. In this exploratory study, we focused on miR‑34a‑5p because of its well‑documented involvement in neurobiology. To explore a differential profile of circulating miR‑34a‑5p in PD, PD patients and age‑matched control subjects were enrolled. Serial ultracentrifugation steps and density gradient were used to separate EV subpopulations from plasma according to their different sedimentation properties (Large, Medium, Small EVs). Characterization of EV types was performed using western blotting and atomic force microscopy (AFM); purity from protein contaminants was checked with the colorimetric nanoplasmonic assay. Circulating miR‑34a‑5p levels were evaluated using qPCR in plasma and in each EV type. miR‑34a‑5p was significantly up‑regulated in small EVs devoid of exogenous protein contaminants (pure SEVs) from PD patients and ROC analysis indicated a good diagnostic performance in discriminating patients from controls (AUC=0.74, P<0.05). Moreover, miR‑34a‑5p levels in pure SEVs were associated with disease duration, Hoehn and Yahr and Beck Depression Inventory scores. These results underline the necessity to examine the miRNA content of each EV subpopulation to identify miRNA candidates with potential diagnostic value and lay the basis for future studies to validate the overexpression of circulating miR‑34a‑5p in PD via the use of pure SEVs.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Tysnes OB and Storstein A: Epidemiology of Parkinson's disease. J Neural Transm (Vienna). 12:901–905. 2017. View Article : Google Scholar

2 

Spillantini MG and Goedert M: Neurodegeneration and the ordered assembly of α-synuclein. Cell Tissue Res. 373:137–148. 2018. View Article : Google Scholar

3 

Bellucci A, Mercuri NB, Venneri A, Faustini G, Longhena F, Pizzi M, Missale C and Spano P: parkinson's disease: From synaptic loss to connectome dysfunction. Neuropathol Appl Neurobiol. 42:77–94. 2016. View Article : Google Scholar

4 

Thompson AG, Gray E, Heman-Ackah SM, Mäger I, Talbot K, El Andaloussi S, Wood MJ and Turner MR: Extracellular vesicles in neurodegenerative disease-pathogenesis to biomarkers. Nat Rev Neurol. 12:346–357. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Tofaris GK: A critical assessment of exosomes in the pathogenesis and stratification of parkinson's disease. J Parkinsons Dis. 7:569–579. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Paolini L, Federici S, Consoli G, Arceri D, Radeghieri A, Alessandri I and Bergese P: Fourier-Transform infrared (FT-IR) spectroscopy fingerprints subpopulations of extracellular vesicles of different sizes and cellular origin. J Extracell Vesicles. 9:17411742020. View Article : Google Scholar : PubMed/NCBI

7 

Tomlinson PR, Zheng Y, Fischer R, Heidasch R, Gardiner C, Evetts S, Hu M, Wade-Martins R, Turner MR, Morris J, et al: Identification of distinct circulating exosomes in parkinson's disease. Ann Clin Transl Neurol. 2:353–361. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Gui YX, Liu H, Zhang LS, Lv W and Hu XY: Altered microRNA profiles in cerebrospinal fluid exosome in parkinson disease and alzheimer disease. Oncotarget. 10:37043–37053. 2015. View Article : Google Scholar

9 

Cao XY, Lu JM, Zhao ZQ, Li MC, Lu T, An XS and Xue LJ: MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles. Neurosci Lett. 644:94–99. 2017. View Article : Google Scholar : PubMed/NCBI

10 

Yao YF, Qu MW, Li GC, Zhang FB and Rui HC: Circulating exosomal miRNAs as diagnostic biomarkers in parkinson's disease. Eur Rev Med Pharmacol Sci. 22:5278–5283. 2018.PubMed/NCBI

11 

Mateescu B, Kowal EJ, van Balkom BW, Bartel S, Bhattacharyya SN, Buzás EI, Buck AH, de Candia P, Chow FW, Das S, et al: Obstacles and opportunities in the functional analysis of extracellular vesicle RNA-an ISEV position paper. J Extracell vesicles. 6:12860952017. View Article : Google Scholar

12 

Chua CE and Tan BL: MiR-34a in neurophysiology and neuropathology. J Mol Neurosci. 67:235–246. 2019. View Article : Google Scholar

13 

van den Berg MM, Krauskopf J, Ramaekers JG, Kleinjans JC, Prickaerts J and Briedé JJ: Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders. Prog Neurobiol. 185:1017322020. View Article : Google Scholar

14 

Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, et al: Movement disorder society-sponsored revision of the unified parkinson's disease rating scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord. 22:41–47. 2007. View Article : Google Scholar

15 

Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, et al: Movement disorder society task force report on the hoehn and yahr staging scale: Status and recommendations. Mov Disord. 19:1020–1028. 2004. View Article : Google Scholar : PubMed/NCBI

16 

Beck AT, Ward CH, Mendelson M, Mock J and Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry. 4:561–571. 1961. View Article : Google Scholar : PubMed/NCBI

17 

Witwer KW, Buzás EI, Bemis LT, Bora A, Lässer C, Lötvall J, Nolte-'t Hoen EN, Piper MG, Sivaraman S, Skog J, et al: Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2:272013. View Article : Google Scholar

18 

Coumans FA, Brisson AR, Buzas EI, Dignat-George F, Drees EE, El-Andaloussi S, Emanueli C, Gasecka A, Hendrix A, Hill AF, et al: Methodological guidelines to study extracellular vesicles. Circ Res. 120:1632–1648. 2017. View Article : Google Scholar : PubMed/NCBI

19 

Lacroix R, Judicone C, Mooberry M, Boucekine M, Key NS and Dignat-George F; The ISTH SSC Workshop: Standardization of pre-analytical variables in plasma microparticle determination: Results of the international society on thrombosis and haemostasis SSC collaborative workshop. J Thromb Haemost. 11:11902013. View Article : Google Scholar

20 

Van Deun J, Mestdagh P, Agostinis P, Akay Ö, Anand S, Anckaert J, Martinez ZA, Baetens T, Beghein E, Bertier L, et al: EV-TRACK: Transparent reporting and centralizing knowledge in extracellular vesicle research. Nat Methods. 28:228–232. 2017. View Article : Google Scholar

21 

Paolini L, Zendrini A, Di Noto G, Busatto S, Lottini E, Radeghieri A, Dossi A, Caneschi A, Ricotta D and Bergese P: Residual matrix from different separation techniques impacts exosome biological activity. Sci Rep. 6:235502016. View Article : Google Scholar : PubMed/NCBI

22 

Di Noto G, Chiarini M, Paolini LL, Mazzoldi EL, Giustini V, Radeghieri A, Caimi L and Ricotta D: Immunoglobulin free light chains and GAGs mediate multiple myeloma extracellular vesicles uptake and secondary NfκB nuclear translocation. Front Immunol. 5:5172014. View Article : Google Scholar

23 

Di Noto G, Paolini L, Zendrini A, Radeghieri A, Caimi L and Ricotta D: C-Src enriched serum microvesicles are generated in malignant plasma cell dyscrasia. PLoS One. 8:e708112013. View Article : Google Scholar : PubMed/NCBI

24 

Paolini L, Radeghieri A, Civini S, Caimi L and Ricotta D: The epsilon hinge-ear region regulates membrane localization of the AP-4 complex. Traffic. 12:1604–1619. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Alvisi G, Paolini L, Contarini A, Zambarda C, Di Antonio V, Colosini A, Mercandelli N, Timmoneri M, Palù G, Caimi L, et al: Intersectin goes nuclear: Secret life of an endocytic protein. Biochem J. 475:1455–1472. 2018. View Article : Google Scholar : PubMed/NCBI

26 

Jeppesen DK, Fenix AM, Franklin JL, Higginbotham JN, Zhang Q, Zimmerman LJ, Liebler DC, Ping J, Liu Q, Evans R, et al: Reassessment of exosome composition. Cell. 177:428–445. 2019. View Article : Google Scholar : PubMed/NCBI

27 

Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, Dingli F, Loew D, Tkach M and Théry C: Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci USA. 113:E968–E977. 2016. View Article : Google Scholar : PubMed/NCBI

28 

Radeghieri A, Savio G, Zendrini A, Di Noto G, Salvi A, Bergese P and Piovani G: Cultured human amniocytes express hTERT, which is distributed between nucleus and cytoplasm and is secreted in extracellular vesicles. Biochem Biophys Res Commun. 483:706–711. 2017. View Article : Google Scholar

29 

Berardocco M, Radeghieri A, Busatto S, Gallorini M, Raggi C, Gissi C, D'Agnano I, Bergese P, Felsani A and Berardi AC: RNA-Seq reveals distinctive RNA profiles of small extracellular vesicles from different human liver cancer cell lines. Oncotarget. 8:82920–82939. 2017. View Article : Google Scholar : PubMed/NCBI

30 

Vescovi R, Monti M, Moratto D, Paolini L, Consoli F, Benerini L, Melocchi L, Calza S, Chiudinelli M, Rossi G, et al: Collapse of the plasmacytoid dendritic cell compartment in advanced cuta-neous melanomas by components of the tumor cell secretome. Cancer Immunol Res. 7:12–28. 2019. View Article : Google Scholar

31 

Horcas I, Fernández R, Gómez-Rodríguez JM, Colchero J, Gómez-Herrero J and Baro AM: WSXM: A software for scanning probe microscopy and a tool for nanotechnology. Rev Sci Instrum. 78:0137052007. View Article : Google Scholar : PubMed/NCBI

32 

Maiolo D, Paolini L, Di Noto G, Zendrini A, Berti D, Bergese P and Ricotta D: Colorimetric nanoplasmonic assay to determine purity and titrate extracellular vesicles. Anal Chem. 87:4168–4176. 2015. View Article : Google Scholar : PubMed/NCBI

33 

Zendrini A, Paolini L, Busatto S, Radeghieri A, Romano M, Wauben MH, van Herwijnen MJ, Nejsum P, Borup A, Ridolfi A, et al: Augmented COlorimetric NANoplasmonic (CONAN) method for grading purity and determine concentration of EV microliter volume solutions. Front Bioeng Biotechnol. 7:4522019. View Article : Google Scholar

34 

Salvi A, Vezzoli M, Busatto S, Paolini L, Faranda T, Abeni E, Caracausi M, Antonaros F, Piovesan A, Locatelli C, et al: Analysis of a nanoparticle-enriched fraction of plasma reveals miRNA candidates for down syndrome pathogenesis. Int J Mol Med. 43:2303–2318. 2019.PubMed/NCBI

35 

Sticht C, De La Torre C, Parveen A and Gretz N: Mirwalk: An online resource for prediction of microrna binding sites. PLoS One. 18:e02062392018. View Article : Google Scholar

36 

Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol. 4:P32003. View Article : Google Scholar : PubMed/NCBI

37 

Grossi I, Salvi A, Abeni E, Marchina E and De Petro G: Biological function of MicroRNA193a-3p in health and disease. Int J Genomics. 2017:59131952017. View Article : Google Scholar : PubMed/NCBI

38 

Faranda T, Grossi I, Manganelli M, Marchina E, Baiocchi G, Portolani N, Crosatti M, De Petro G and Salvi A: Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib. Sci Rep. 9:91182019. View Article : Google Scholar : PubMed/NCBI

39 

Grossi I, Arici B, Portolani N, De Petro G and Salvi A: Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma. Oncotarget. 8:6955–6969. 2017. View Article : Google Scholar :

40 

Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK, et al: Minimal information for studies of extra-cellular vesicles 2018 (MISEV2018): A position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 7:15357502018. View Article : Google Scholar

41 

Mollinari C, Racaniello M, Berry A, Pieri M, De Stefano MC, Cardinale A, Zona C, Cirulli F, Garaci E and Merlo D: MiR-34a regulates cell proliferation, morphology and function of newborn neurons resulting in improved behavioural outcomes. Cell Death Dis. 6:e16222015. View Article : Google Scholar : PubMed/NCBI

42 

Agostini M, Tucci P, Steinert JR, Shalom-Feuerstein R, Rouleau M, Aberdam D, Forsythe ID, Young KW, Ventura A, Concepcion CP, et al: microRNA-34a regulates neurite outgrowth, spinal morphology, and function. Proc Natl Acad Sci USA. 108:21099–21104. 2011. View Article : Google Scholar : PubMed/NCBI

43 

Morgado AL, Xavier JM, Dionísio PA, Ribeiro MF, Dias RB, Sebastião AM, Solá S and Rodrigues CM: MicroRNA-34a modulates neural stem cell differentiation by regulating expression of synaptic and autophagic proteins. Mol Neurobiol. 51:1168–11183. 2015. View Article : Google Scholar

44 

Bavamian S, Mellios N, Lalonde J, Fass DM, Wang J, Sheridan SD, Madison JM, Zhou F, Rueckert EH, Barker D, et al: Dysregulation of miR-34a links neuronal development to genetic risk factors for bipolar disorder. Mol Psychiatry. 20:573–584. 2015. View Article : Google Scholar : PubMed/NCBI

45 

Modi PK, Jaiswal S and Sharma P: Regulation of neuronal cell cycle and apoptosis by MicroRNA 34a. Mol Cell Biol. 36:84–94. 2016.

46 

Wang X, Liu P, Zhu H, Xu Y, Ma C, Dai X, Huang L, Liu Y, Zhang L and Qin C: MiR-34a, a microRNA up-regulated in a double transgenic mouse model of alzheimer's disease, inhibits bcl2 translation. Brain Res Bull. 28:268–273. 2009. View Article : Google Scholar

47 

Aranha MM, Santos DM, Solá S, Steer CJ and Rodrigues MP: MiR-34a regulates mouse neural stem cell differentiation. PLoS One. 6:e213962011. View Article : Google Scholar : PubMed/NCBI

48 

Dias BG, Goodman JV, Ahluwalia R, Easton AE, Andero R and Ressler KJ: Amygdala-Dependent Fear Memory Consolidation via miR-34a and Notch Signaling. Neuron. 20:906–918. 2014. View Article : Google Scholar

49 

Liu N, Landreh M, Cao K, Abe M, Hendriks GJ, Kennerdell JR, Zhu Y, Wang LS and Bonini NM: The microRNA miR-34 modulates ageing and neurodegeneration in drosophila. Nature. 15:519–523. 2012. View Article : Google Scholar

50 

Kennerdell JR, Liu N and Bonini NM: MiR-34 inhibits poly-comb repressive complex 2 to modulate chaperone expression and promote healthy brain aging. Nat Commun. 10:41882018. View Article : Google Scholar

51 

Cheng L, Sharples RA, Scicluna BJ and Hill AF: Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles. 3:262014. View Article : Google Scholar

52 

Leggio L, Vivarelli S, L'Episcopo F, Tirolo C, Caniglia S, Testa N, Marchetti B and Iraci N: MicroRNAs in parkinson's disease: From pathogenesis to novel diagnostic and therapeutic approaches. Int J Mol Sci. 18:26982017. View Article : Google Scholar

53 

Wang L and Zhang L: Circulating exosomal miRNA as diag-nostic biomarkers of neurodegenerative diseases. Front Mol Neurosci. 13:532020. View Article : Google Scholar

54 

Crescitelli R, Lässer C, Szabó TG, Kittel A, Eldh M, Dianzani I, Buzás EI and Lötvall J: Distinct RNA profiles in subpopulations of extracellular vesicles: Apoptotic bodies, microvesicles and exosomes. J Extracell vesicles. 2:122013. View Article : Google Scholar

55 

Lunavat TR, Cheng L, Kim DK, Bhadury J, Jang SC, Lässer C, Sharples RA, López MD, Nilsson J, Gho YS, et al: Small RNA deep sequencing discriminates subsets of extracellular vesicles released by melanoma cells-Evidence of unique microRNA cargos. RNA Biol. 12:810–823. 2015. View Article : Google Scholar :

56 

Enderle D, Spiel A, Coticchia CM, Berghoff E, Mueller R, Schlumpberger M, Sprenger-Haussels M, Shaffer JM, Lader E, Skog J and Noerholm M: Characterization of RNA from exosomes and other extracellular vesicles isolated by a novel spin column-based method. PLoS One. 10:e01361332015. View Article : Google Scholar : PubMed/NCBI

57 

Ravanidis S, Bougea A, Papagiannakis N, Maniati M, Koros C, Simitsi A, Bozi M, Pachi I, Stamelou M, Paraskevas GP, et al: Circulating brain-enriched MicroRNAs for detection and discrimination of idiopathic and genetic parkinson's disease. Mov Disord. 35:457–467. 2020. View Article : Google Scholar

58 

Bak M, Silahtaroglu A, Møller M, Christensen M, Rath MF, Skryabin B, Tommerup N and Kauppinen S: MicroRNA expression in the adult mouse central nervous system. RNA. 14:432–444. 2008. View Article : Google Scholar : PubMed/NCBI

59 

Jauhari A, Singh T, Singh P, Parmar D and Yadav S: Regulation of miR-34 family in neuronal development. Mol Neurobiol. 55:936–945. 2018. View Article : Google Scholar

60 

Sarkar S, Jun S, Rellick S, Quintana DD, Cavendish JZ and Simpkins JW: Expression of microRNA-34a in alzheimer's disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity. Brain Res. 1646:139–151. 2016. View Article : Google Scholar : PubMed/NCBI

61 

Agostini M, Tucci P, Killick R, Candi E, Sayan BS, di Val Cervo PR, Nicoterad P, McKeon F, Knight RA, Mak TW and Melino G: Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets. Proc Natl Acad Sci USA. 108:21093–21098. 2011. View Article : Google Scholar : PubMed/NCBI

62 

Briggs CE, Wang Y, Kong B, Woo TU, Iyer LK and Sonntag KC: Midbrain dopamine neurons in parkinson's disease exhibit a dysregulated miRNA and target-gene network. Brain Res. 1618:111–121. 2015. View Article : Google Scholar : PubMed/NCBI

63 

Delavar RM, Baghi M, Safaeinejad Z, Kiani-Esfahani A, Ghaedi K and Nasr-Esfahani MH: Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of parkinson's disease. Gene. 662:54–65. 2018. View Article : Google Scholar

64 

Horst CH, Schlemmer F, de Aguiar Montenegro N, Domingues AC, Ferreira GG, da Silva Ribeiro CY, de Andrade RR, Del Bel Guimarães E, Titze-de-Almeida SS and Titze-de-Almeida R: Signature of aberrantly expressed microRNAs in the striatum of rotenone-induced parkinsonian rats. Neurochem Res. 43:2132–2140. 2018. View Article : Google Scholar : PubMed/NCBI

65 

Ba Q, Cui C, Wen L, Feng S, Zhou J and Yang K: Schisandrin B shows neuroprotective effect in 6-OHDA-induced parkinson's disease via inhibiting the negative modulation of miR-34a on Nrf2 pathway. Biomed Pharmacother. 75:165–172. 2015. View Article : Google Scholar : PubMed/NCBI

66 

Alural B, Ozerdem A, Allmer J, Genc K and Genc S: Lithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cells. Front Cell Neurosci. 9:2092015. View Article : Google Scholar : PubMed/NCBI

67 

Horst CH, Titze-De-Almeida R and Titze-De-Almeida SS: The involvement of eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SH-SY5Y cells. Mol Med Rep. 15:1479–1488. 2017. View Article : Google Scholar : PubMed/NCBI

68 

Cosín-Tomás M, Antonell A, Lladó A, Alcolea D, Fortea J, Ezquerra M, Lleó A, Martí MJ, Pallàs M, Sanchez-Valle R, et al: Plasma miR-34a-5p and miR-545-3p as early biomarkers of alzheimer's disease: Potential and limitations. Mol Neurobiol. 54:5550–5562. 2017. View Article : Google Scholar

69 

Mao S, Sun Q, Xiao H, Zhang C and Li L: Secreted miR-34a in astrocytic shedding vesicles enhanced the vulnerability of dopaminergic neurons to neurotoxins by targeting Bcl-2. Protein Cell. 6:529–540. 2015. View Article : Google Scholar : PubMed/NCBI

70 

Wan Y, Liu Y, Wang X, Wu J, Liu K, Zhou J, Liu L and Zhang C: Identification of differential microRNAs in cerebrospinal fluid and serum of patients with major depressive disorder. PLoS One. 10:e01219752015. View Article : Google Scholar : PubMed/NCBI

71 

Ohmichi T, Mitsuhashi M, Tatebe H, Kasai T, El-Agnaf OA and Tokuda T: Quantification of brain-derived extracellular vesicles in plasma as a biomarker to diagnose parkinson's and related diseases. Park Relat Disord. 61:82–87. 2019. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Grossi I, Radeghieri A, Paolini L, Porrini V, Pilotto A, Padovani A, Marengoni A, Barbon A, Bellucci A, Pizzi M, Pizzi M, et al: MicroRNA‑34a‑5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study. Int J Mol Med 47: 533-546, 2021.
APA
Grossi, I., Radeghieri, A., Paolini, L., Porrini, V., Pilotto, A., Padovani, A. ... De Petro, G. (2021). MicroRNA‑34a‑5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study. International Journal of Molecular Medicine, 47, 533-546. https://doi.org/10.3892/ijmm.2020.4806
MLA
Grossi, I., Radeghieri, A., Paolini, L., Porrini, V., Pilotto, A., Padovani, A., Marengoni, A., Barbon, A., Bellucci, A., Pizzi, M., Salvi, A., De Petro, G."MicroRNA‑34a‑5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study". International Journal of Molecular Medicine 47.2 (2021): 533-546.
Chicago
Grossi, I., Radeghieri, A., Paolini, L., Porrini, V., Pilotto, A., Padovani, A., Marengoni, A., Barbon, A., Bellucci, A., Pizzi, M., Salvi, A., De Petro, G."MicroRNA‑34a‑5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study". International Journal of Molecular Medicine 47, no. 2 (2021): 533-546. https://doi.org/10.3892/ijmm.2020.4806
Copy and paste a formatted citation
x
Spandidos Publications style
Grossi I, Radeghieri A, Paolini L, Porrini V, Pilotto A, Padovani A, Marengoni A, Barbon A, Bellucci A, Pizzi M, Pizzi M, et al: MicroRNA‑34a‑5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study. Int J Mol Med 47: 533-546, 2021.
APA
Grossi, I., Radeghieri, A., Paolini, L., Porrini, V., Pilotto, A., Padovani, A. ... De Petro, G. (2021). MicroRNA‑34a‑5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study. International Journal of Molecular Medicine, 47, 533-546. https://doi.org/10.3892/ijmm.2020.4806
MLA
Grossi, I., Radeghieri, A., Paolini, L., Porrini, V., Pilotto, A., Padovani, A., Marengoni, A., Barbon, A., Bellucci, A., Pizzi, M., Salvi, A., De Petro, G."MicroRNA‑34a‑5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study". International Journal of Molecular Medicine 47.2 (2021): 533-546.
Chicago
Grossi, I., Radeghieri, A., Paolini, L., Porrini, V., Pilotto, A., Padovani, A., Marengoni, A., Barbon, A., Bellucci, A., Pizzi, M., Salvi, A., De Petro, G."MicroRNA‑34a‑5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study". International Journal of Molecular Medicine 47, no. 2 (2021): 533-546. https://doi.org/10.3892/ijmm.2020.4806
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team